Louis Ferrari
Nessuna posizione attualmente
Profilo
Louis Ferrari served as the President, Chief Executive Officer & Director at Savient Pharmaceuticals, Inc. from 2012 to 2013.
He holds an MBA from Adelphi University and an undergraduate degree from Arnold & Marie Schwartz College of Pharmacy & Health Science.
Precedenti posizioni note di Louis Ferrari
| Società | Posizione | Fine |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Amministratore Delegato | 20/06/2013 |
Formazione di Louis Ferrari
| Adelphi University | Masters Business Admin |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
- Borsa valori
- Insiders
- Louis Ferrari